IMMUNIC, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$103.2 | -$98.1 | -$99.2 | -$119.5 | -$91.7 |
| Net income | -$97.2 | -$100.5 | -$93.6 | -$120.4 | -$92.9 |
| Cash Flow Statement | |||||
| Free cash flow | -$86.0 | -$85.0 | -$71.2 | -$65.3 | -$83.3 |
Shares outstanding 13.6M · Free float 25.6%
Annual filing data through FY ended December 31, 2025; float as of September 27, 2026.